Protagenic Therapeutics, Inc. (OTC:PTIX) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of shares of common stock, pre-funded warrants and common warrants Announced: US$1.5M–US$5M · two series of milestone-linked warrants that may provide up to $3.5 million in… · Brookline Capital Markets, a division of Arcadia Securities, LLC Dealers: Brookline Capital Markets, a division of Arcadia Securities, LLC (lead) Use of proceeds: Complete IND-enabling activities for PT00114, start its Phase 1/2a trial in Generalized Anxiety Disorder, and working capital and general corporate purposes | Nov 11, 2026 |